{"schema_version":"secwatch.filing_event.v1","accession":"0001801170-25-000279","form_type":"8-K","ticker":"CLOV","cik":"0001801170","company_name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","filed_at":"2025-11-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.499684+00:00","generated_at":"2026-05-16T21:23:14.509862+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"low","headline":"Clover Health publishes supplemental Q&A on Q3 2025 earnings; no new financial figures disclosed","bullets":["Filed under Regulation FD on Nov 12, 2025; document contains written responses to shareholder questions.","Q&A covers strategic direction and topics from Q3 2025 earnings call but provides no additional financial metrics.","CEO Andrew Toy emphasizes commitment to transparency and two-way shareholder communication.","No guidance changes, operational updates, or material non-public information included in the exhibit."],"urls":{"canonical":"https://secwatch.observer/filing/0001801170-25-000279","json":"https://secwatch.observer/filing/0001801170-25-000279.json","markdown":"https://secwatch.observer/filing/0001801170-25-000279.md","text":"https://secwatch.observer/filing/0001801170-25-000279.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1801170/000180117025000279/0001801170-25-000279-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1801170/000180117025000279/clov-20251112.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T21:23:14.509862+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}